Anzeige
Mehr »
Dienstag, 03.03.2026 - Börsentäglich über 12.000 News
Erste Psilocybin-Behandlungen laufen - warum steht Optimi noch bei Pennystock-Level?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DL82 | ISIN: FR001400AHX6 | Ticker-Symbol: 9BK0
Frankfurt
02.03.26 | 15:25
3,200 Euro
-10,61 % -0,380
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ABL DIAGNOSTICS SA Chart 1 Jahr
5-Tage-Chart
ABL DIAGNOSTICS SA 5-Tage-Chart
RealtimeGeldBriefZeit
5,0008,00002.03.

Aktuelle News zur ABL DIAGNOSTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
19.02.ABL Diagnostics S.A.: ABL Diagnostics Update Regarding Non-Binding Letter of Intent244Regulatory News: ABL Diagnostics S.A. (Euronext: ABLD ISIN: FR001400AHX6) informs the market that the non-binding Letter of Intent entered into between ProPhase Labs, Inc. and Advanced Biological...
► Artikel lesen
13.02.ABL Diagnostics SA: ABL SA Executes the First Purchase Notice of ABL Diagnostics Shares With Alumni Capital401Regulatory News: ISIN: FR001400AHX6 Euronext Paris ABL Diagnostics SA ("the Company") (Paris:ABLD) informs the public that its principal shareholder, Advanced Biological Laboratories SA (ABL...
► Artikel lesen
03.02.ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL297Regulatory News: ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the...
► Artikel lesen
19.12.25ABL Diagnostics Informs the Market of a Non-Binding Letter of Intent Between ABL S.A. and ProPhase Labs (Nasdaq: PRPH) for a Proposed Reverse Merger380The contemplated transaction remains subject to due diligence, definitive agreements, regulatory approvals and Nasdaq listing requirements; no change to ABL S.A.'s control over ABL Diagnostics at...
► Artikel lesen
ABL DIAGNOSTICS Aktie jetzt für 0€ handeln
05.12.25ABL Diagnostics S.A.: Information on a Temporary Transfer of ABL Diagnostics Shares344Regulatory News: ABL Diagnostics S.A. (ISIN: FR001400AHX6, ticker: ABLD, listed on Euronext Paris) informs its shareholders and the market that a temporary transfer of 128,026 shares of the company...
► Artikel lesen
14.11.25ABL Diagnostics Appoints Eurobio Scientific as Exclusive Distributor for Its VELA Product Line in a Targeted Segment of the French Market327Regulatory News: ABL Diagnostics (Euronext Paris: ABLD), a French company specializing in advanced molecular diagnostics, announces the signing of an exclusive distribution agreement with Eurobio...
► Artikel lesen
22.10.25ABL Diagnostics SA: ABL Diagnostics - Announcement of a Second Agreement Between ABL SA and Alumni Capital274Regulatory News: ISIN: FR001400AHX6 Euronext Paris ABL Diagnostics SA (the "Company") (Paris:ABLD) informs the public that Advanced Biological Laboratories SA (ABL SA), its parent company, announced...
► Artikel lesen
16.10.25ABL Diagnostics SA: ABL Diagnostics: Switch to Continuous Trading on Euronext Paris as From November 3rd, 2025342Regulatory News: ABL Diagnostics (Euronext Paris: ABLD ISIN: FR001400AHX6) announces the switch from a fixing-based trading mode to continuous trading as from November 3rd, 2025, in accordance...
► Artikel lesen
8 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1